Site hosted by Build your free website today!

Reference List


Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER and Bourtchouladze R.  Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88: 615-626, 1997.


Aggleton JP and Brown MW. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav.Brain Sci. 22: 425-444, 1999.


Aguayo LG, Peoples RW, Yeh HH and Yevenes GE.  GABA (A) receptors as molecular sites of ethanol action. Direct or indirect actions?  Curr Top Med Chem. 2:869-885, 2002.


Al Ghoul WM, Herman MD and Dubocovich ML. Melatonin receptor subtype expression in human cerebellum. Neuroreport 9: 4063-4068, 1998.


Andersen P, Bliss TV and Skrede KK. Unit analysis of hippocampal population spikes. Exp.Brain Res. 13: 208-221, 1971.


Anis Y, Nir I and Zisapel N. Diurnal variations in melatonin binding sites in the hamster brain: impact of melatonin. Mol.Cell Endocrinol. 121-129, 1989.


Anton-Tay F, Ramirez G, Martinez I and Benitez-King G. In vitro stimulation of protein kinase C by melatonin. Neurochem.Res. 23: 601-606, 1998.


Arendt J. Melatonin, circadian rhythms, and sleep. N.Engl.J.Med. 343: 1114-1116, 2000.


Arendt J and Broadway J. Light and melatonin as zeitgebers in man. Chronobiol.Int. 4: 273-282, 1987.


Arendt J, Deacon S, English J, Hampton S and Morgan L. Melatonin and adjustment to phase shift. J.Sleep Res. 4: 74-79, 1995.


Arushanian EB and Beier EV.  The participation of the dorsal hippocampus in the antianxiety action of melatonin and diazepam. Eksp.Klin.Farmakol. 61: 13-16, 1998.


Avshalumov MV and Rice ME.  NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices.  J Neurophysiol. 87:2896-2903, 2002.


Axelrod J, Quay WB and Baker PC. Enzymatic synthesis of the skin-lightening agent, melatonin, in amphibians. Nature 208: 386, 1965.


Axelrod J, Snyder SH, Heller A and Moore RY. Light-induced changes in pineal hydroxyindole-O-methyltransferase: abolition by lateral hypothalamic lesions. Science 154: 898-899, 1966.


Bach ME, Hawkins RD, Osman M, Kandel ER and Mayford M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81: 905-915, 1995.


Barnes CA. Involvement of LTP in memory: are we searching under the street light? Neuron 15:751-754, 1995.


Barrett P, Davidson G, Hazlerigg DG, Morris MA, Ross AW and Morgan PJ. Mel 1a melatonin receptor expression is regulated by protein kinase C and an additional pathway addressed by the protein kinase C inhibitor Ro 31-8220 in ovine pars tuberalis cells. Endocrinology 139: 163-171, 1998.


Baskys A and Malenka RC. Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus. J.Physiol 444: 687-701, 1991.


Bekkers JM and Stevens ChF.  Presynaptic mechanism for long-term potentiation in the hippocampus.  Nature 346:724-729, 1990.


Benitez-King G and Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 49: 635-641, 1993.


Benitez-King G, Hernandez ME, Tovar R and Ramirez G. Melatonin activates PKC-alpha but not PKC-epsilon in N1E-115 cells. Neurochem.Int. 39: 95-102, 2001.


Benitez-King G, Huerto-Delgadillo L and Anton-Tay F. Melatonin modifies calmodulin cell levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro. Brain Res. 557: 289-292, 1991.


Benitez-King G, Huerto-Delgadillo L and Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci. 53: 201-207, 1993.


Benitez-King G, Rios A, Martinez A and Anton-Tay F. In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin. Biochim.Biophys.Acta 1290: 191-196, 1996.


Bennett JP and Snyder SH. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors. Brain Res. 94: 523-544, 1975.


Benson B and Krasovich M. Circadian rhythm in the number of granulated vesicles in the pinealocytes of mice. Effects of sympathectomy and melatonin treatment. Cell Tissue Res. 184: 499-506, 1977.


Beresford IJ, Browning C, Starkey SJ, Brown J, Foord SM, Coughlan J, North PC, Dubocovich ML and Hagan RM. GR196429: a nonindolic agonist at high-affinity melatonin receptors. J.Pharmacol.Exp.Ther. 285: 1239-1245, 1998.


Bittman EL, Karsch FJ and Hopkins JW. Role of the pineal gland in ovine photoperiodism: regulation of seasonal breeding and negative feedback effects of estradiol upon luteinizing hormone secretion. Endocrinology 113: 329-336, 1983.


Bittman EL and Weaver DR. The distribution of melatonin binding sites in neuroendocrine tissues of the ewe. Biol.Reprod. 43: 986-993, 1990.


Bliss TV and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J.Physiol 232: 331-356, 1973.


Blumenau C, Berger E, Fauteck JD, Madeja M, Wittkowski W, Speckmann EJ and Musshoff U. Expression and functional characterization of the mt1 melatonin receptor from rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol pathway. J.Pineal Res. 30: 139-146, 2001.


Bordt SL, McKeon RM, Li PK, Witt-Enderby PA and Melan MA.  N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin.  Biochim Biophys Acta 1499:257-264, 2001.


Borjigin J, Li X and Snyder SH. The pineal gland and melatonin: molecular and pharmacologic regulation. Annu.Rev.Pharmacol.Toxicol. 39: 53-65, 1999.


Brinklow BR and Loudon AS. Evidence for a circannual rhythm of reproduction and prolactin secretion in a seasonally breeding macropodid marsupial, the Bennett's wallaby (Macropus rufogriseus rufogriseus). J.Reprod.Fertil. 98: 625-630, 1993.


Brodkin J.  Assessing memory in mice using habituation of nose-poke responding. Behav. Pharmacol.10:445-451, 1999.


Brown P and Dale N.  Modulation of K(+) currents in Xenopus spinal neurons by p2y receptors: a role for ATP and ADP in motor pattern generation.  J Physiol. 540:843-850, 2002.



Brusco LI, Garcia-Bonacho M, Esquifino AI and Cardinali DP. Diurnal rhythms in norepinephrine and acetylcholine synthesis of sympathetic ganglia, heart and adrenals of aging rats: effect of melatonin. J.Auton.Nerv.Syst. 74: 49-61, 1998.


Brzezinski A. Melatonin in health and disease. Fertil.Steril. 55: 1025, 1991.


Bubenik, G. A., Niles, L. P., Pang, S. F., and Pentney, P. J. Diurnal variation and binding characteristics of melatonin in the mouse brain and gastrointestinal tissues. Comp Biochem.Physiol C. 104: 221-224, 1993.


Buonomano DV, Merzenick MM.  Transformation of temporal information into a spatial code by a neural network based on realistic neuronal properties. Science 267:1028-1031, 1995.


Burkhardt S, Reiter RJ, Tan DX, Hardeland R, Cabrera J and Karbownik M. DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5- methoxykynuramine, resveratrol and uric acid. Int.J.Biochem.Cell Biol. 33: 775-783, 2001.


Buzsaki G.  Feed-forward inhibition in the hippocampal formation. Progr Neurobiol 22:131-153, 1984.


Cabrera J, Reiter RJ, Tan DX, Qi W, Sainz RM, Mayo JC, Garcia JJ, Kim SJ and El Sokkary G. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology 39: 507-514, 2000.


Cagnacci A, Soldani R and Yen SS. The effect of light on core body temperature is mediated by melatonin in women. J.Clin.Endocrinol.Metab 76: 1036-1038, 1993.


Cahill GM. Circadian regulation of melatonin production in cultured zebrafish pineal and retina. Brain Res. 708: 177-181, 1996.


Cahill GM and Besharse JC. Retinal melatonin is metabolized within the eye of xenopus laevis. Proc.Natl.Acad.Sci.U.S.A 86: 1098-1102, 1989.


Camacho J and Sanchez JA.  Inactivation of I(A) channels of frog skeletal muscle is modulated by ATP.  Biochem Biophys Res Commun. 291:1287-1292, 2002.


Cantrell AR, Tibbs VC, Westenbroek RE, Scheuer T and Catterall WA.  Dopaminergic modulation of voltage-gated Na+ current in rat hippocampal neurons requires anchoring of cAMP-dependent protein kinase.  J Neurosci. 19:RC21, 1999.


Cardinal RN, Parkinson JA, Hall J and Everitt BJ.  Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex.  Neurosci Biobehav Rev. 26:321-352, 2002.


Cardinali DP, Golombek DA, Rosenstein RE, Cutrera RA and Esquifino AI. Melatonin site and mechanism of action: single or multiple? J.Pineal Res. 23: 32-39, 1997.


Cardinali DP, Vacas MI and Boyer EE. Specific binding of melatonin in bovine brain. Endocrinology 105: 437-441, 1979.


Carlson LL, Weaver DR and Reppert SM. Melatonin signal transduction in hamster brain: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein. Endocrinology 125: 2670-2676, 1989.


Carter AG, Vogt KE, Foster KA and Regehr WG.  Assessing the role of calcium-induced calcium release in short-term presynaptic plasticity at excitatory central synapses.  J Neurosci 22:21-28, 2002.


Cazevieille C and Osborne NN. Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not -- melatonin counteracts the effects of ischaemia and kainate. Brain Res. 755: 91-100, 1997.


Cazevieille C, Safa R and Osborne NN. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res. 768: 120-124, 1997.


Chen Y, Chad JE and Wheal HV.  Synaptic release rather than failure in the conditioning pulse results in paired-pulse facilitation during minimal synaptic stimulation in the rat hippocampal CA1 neurones.  Neurosci Lett 218:204-208, 1996.


Christie BR and Abraham W.  Differential regulation of paired-pulse plasticity following LTP in the dentate gyrus.  Neuroreport 5:385-388, 1994.


Chu GH, Witt-Enderby PA, Jones M and LI PK. Synthesis and Pharmacological Analysis of High Affinity Melatonin Receptor Ligands. Chem. Pharm. Bull. 50:272-275, 2002.


Chuang TT, LeVine H and De Blasi A. Phosphorylation and activation of beta-adrenergic receptor kinase by protein kinase C. J.Biol.Chem. 270: 18660-18665, 1995.


Ciesla W. Can melatonin regulate the expression of prohormone convertase 1 and 2 genes via monomeric and dimeric forms of RZR/ROR nuclear receptor, and can melatonin influence the processes of embryogenesis or carcinogenesis by disturbing the proportion of cAMP and cGMP concentrations? Theoretic model of controlled apoptosis. Med.Hypotheses 56: 181-193, 2001.


Cohen M, Roselle D, Chabner B, Schmidt TJ and Lippman M. Evidence for a cytoplasmic melatonin receptor. Nature 274: 894-895, 1978.


Collingridge GL, Kehl SJ and McLennan H. The antagonism of amino acid-induced excitations of rat hippocampal CA1 neurones in vitro. J.Physiol 334: 19-31, 1983.


Collins DR and Davies SN. Melatonin blocks the induction of long-term potentiation in an N-methyl- D-aspartate independent manner. Brain Res. 767: 162-165, 1997.


Coloma FM and Niles LP. Melatonin enhancement of [3H]-gamma-aminobutyric acid and [3H]muscimol binding in rat brain. Biochem.Pharmacol. 37: 1271-1274, 1988.


Commins S, Gigg J, Anderson M and O'Mara SM.  Interaction between paired-pulse facilitation and long-term potentiation in the projection from hippocampal area CA1 to the subiculum.  Neuroreport 9:4109-4113, 1998.


Conti A, Maestroni GJ.  HPLC validation of a circadian melatonin rhythm in the pineal gland of inbred mice.  J Pineal Res. 20:138-144, 1996.


Conti, A. and Maestroni, G. J. Melatonin rhythms in mice: role in autoimmune and lymphoproliferative diseases. Ann.N.Y.Acad.Sci. 840: 395-410, 1998.


Conway S, Drew JE, Canning SJ, Barrett P, Jockers R, Strosberg AD, Guardiola-Lemaitre B, Delagrange P and Morgan PJ. Identification of Mel1a melatonin receptors in the human embryonic kidney cell line HEK293: evidence of G protein-coupled melatonin receptors which do not mediate the inhibition of stimulated cyclic AMP levels. FEBS Lett. 407: 121-126, 1997.


Costa EJ, Lopes RH and Lamy-Freund MT. Permeability of pure lipid bilayers to melatonin. J.Pineal Res. 19: 123-126, 1995.


Costa EJ, Shida CS, Biaggi MH, Ito AS and Lamy-Freund MT. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett. 416: 103-106, 1997.


Costa ET, Soto EE, Cardoso RA, Olivera DS and Valenzuela CF.  Acute effects of ethanol on kainate receptors in cultured hippocampal neurons.  Alcohol Clin Exp Res.  2000;24(2): 220-5


Creager R, Dunwiddie T and Lynch G.  Paired-pulse and frequency facilitation in the CA1  region of the in vitro rat hippocampus.  J Physiol 299:409-424, 1980.


Danilenko KV, Putilov AA, Russkikh GS, Duffy LK and Ebbesson SO. Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med.Res. 53: 137-145, 1994.


Deacon SJ and Arendt J. Phase-shifts in melatonin, 6-sulphatoxymelatonin and alertness rhythms after treatment with moderately bright light at night. Clin.Endocrinol.(Oxf) 40: 413-420, 1994.


Deveson S, Howarth JA, Arendt J and Forsyth IA. In vitro autoradiographical localization of melatonin binding sites in the caprine brain. J.Pineal Res. 13: 6-12, 1992.


Dittman JS, Kreitzer AC and Regehr WG.  Interplay between facilitation, depression, and residual calcium at three presynaptic terminals. J Neurosci 20:1374-1385, 2000.


Dubocovich ML.  Melatonin is a potent modulator of dopamine release in the retina. Nature 306: 782-784, 1983.


Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol.Sci. 16: 50-56, 1995.


Dubocovich ML, Masana MI, Iacob S and Sauri DM. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch.Pharmacol. 355: 365-375, 1997.


Dubocovich ML and Takahashi JS. Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina. Proc.Natl.Acad.Sci.U.S.A 84: 3916-3920, 1987.


Dubocovich ML, Yun K, Al Ghoul WM, Benloucif S and Masana MI. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 12: 1211-1220, 1998.


Duncan MJ, Takahashi JS and Dubocovich ML. Characterization of 2-[125I]iodomelatonin binding sites in hamster brain. Eur.J.Pharmacol. 132: 333-334, 1986.


Eison AS and Mullins UL. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life Sci. 53: L393-L398, 1993.


El-Sherif Y, Hogan MV, Tesoriero J and Wieraszko A. Factors regulating the influence of melatonin on hippocampal evoked potentials: comparative studies on different strains of mice. Brain Res. 945: 191-201, 2002.


El-Sherif Y, Singh N, Khan T and Wieraszko A. The effect of glutamate uptake inhibitors on hippocampal evoked potentials in vitro. Acta Neurobiol.Exp.(Warsz.) 59: 89-97, 1999.


El-Sherif Y, Wieraszko A, Banerjee P and Penington NJ. ATP modulates Na(+) channel gating and induces a non-selective cation current in a neuronal hippocampal cell line. Brain Res. 904: 307-317, 2001.


Escames G, Acuna CD and Vives F. Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat. Neuroreport 7: 597-600, 1996.


Faillace MP, las Heras MA, Sarmiento MI and Rosenstein RE.  Daily variations in 2-[125I]melatonin specific binding in the golden hamster retina. Neuroreport 7: 141-144, 1995.


Faillace MP, Sarmiento MI and Rosenstein RE. Melatonin effect on [3H] glutamate uptake and release in the golden hamster retina. J.Neurochem. 67: 623-628, 1996.


Farr SA, Flood JF, Morley JE.  The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus. Neurobiol. Learn. Mem. 73:150-167, 2000.


Fauteck J, Schmidt H, Lerchl A, Kurlemann G and Wittkowski W. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol.Signals Recept. 8: 105-110, 1999a.


Fauteck JD, Dittgen M, Farker K, Hoffmann A, Hoffmann H, Lerchl A and Wittkowski W. Melatonin and aging: relevance for clinical approach? J. Endocrinol. Invest. 22(10 Suppl):90-91, 1999b.


Flood JF, Morley PM and Morley JE.  Age-related changes in learning, memory, and lipofucin as a function of the percentage of SAMP8 genes. Physiol. Behav. 58:819-822, 1995.



Folkard S, Arendt J and Clark M. Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings. Chronobiol.Int. 10: 315-320, 1993.


Fujieda H, Hamadanizadeh SA, Wankiewicz E, Pang SF and Brown GM. Expression of mt1 melatonin receptor in rat retina: evidence for multiple cell targets for melatonin. Neuroscience 93: 793-799, 1999.


Fukawa E, Tanaka H and Makino I. Identification and characterization of guanine nucleotide-sensitive melatonin receptors in chicken brain. Neuropharmacology 34: 767-776, 1995.


Garcia-Patterson A, Puig-Domingo M and Webb SM. Thirty years of human pineal research: do we know its clinical relevance? J.Pineal Res. 20: 1-6, 1996.


Garcia-Perganeda A, Guerrero JM, Rafii-El-Idrissi M, Paz Romero M, Pozo D and Calvo JR.  Characterization of membrane melatonin receptor in mouse peritoneal macrophages: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein.  J Neuroimmunol 95:85-94, 1999


Gauer F, Masson-Pevet M, Saboureau M, George D and Pevet P. Differential seasonal regulation of melatonin receptor density in the pars tuberalis and the suprachiasmatic nuclei: a study in the hedgehog (Erinaceus europaeus, L.). J.Neuroendocrinol. 5: 685-690, 1993.


Geinisman Y. Structural synaptic modifications associated with hippocampal LTP and behavioral learning. Cereb.Cortex 10: 952-962, 2000a.


Geinisman Y, Disterhoft JF, Gundersen HJ, McEchron MD, Persina IS, Power JM, Van der Zee EA and West MJ. Remodeling of hippocampal synapses after hippocampus-dependent associative learning. J.Comp Neurol. 417: 49-59, 2000b.


Godson C and Reppert SM. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138: 397-404, 1997.


Gonzales RG and Armstrong DL. Effects of melatonin on synaptic transmission and long-term potentiation in the dentate gyrus of the hippocampus. Abstr Soc Neurosci 21: 615.11, 1995.


Gonzalez R, Sanchez A, Ferguson JA, Balmer C, Daniel C, Cohn A and Robinson WA. Melatonin therapy of advanced human malignant melanoma. Melanoma Res. 1: 237-243, 1991.


Gottschalk W, Pozzo-Miller LD, Figurov A and Lu B.  Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus.  J Neurosci. 18:6830-6839, 1998.


Grover LM. Evidence for postsynaptic induction and expression of NMDA receptor independent LTP. J.Neurophysiol. 79: 1167-1182, 1998.


Guardiola-Lemaitre B. Toxicology of melatonin. J.Biol.Rhythms 12: 697-706, 1997.


Gutierrez R, Leff P, Romo-Parra H, Acevedo R and Anton B.  Orpanin-fq/nociception inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibition. Neuroscience 105:325-333, 2000.


Harris KM and Teyler TJ. Age differences in a circadian influence on hippocampal LTP. Brain Res. 262:69-73, 1983.


Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC and Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287: 2262-2267, 2000.


Hazlerigg DG, Gonzalez-Brito A, Lawson W, Hastings MH and Morgan PJ.  Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary.  Endocrinology 132:285-292, 1993.


Hirata F, Hayaishi O, Tokuyama T and Seno S. In vitro and in vivo formation of two new metabolites of melatonin. J.Biol.Chem. 249: 1311-1313, 1974.


Hodde KC. The vascularization of the rat pineal organ. Prog.Brain Res. 52: 39-44, 1979a.


Hodde KC and Veltman WA. The vascularization of the pineal gland (epiphysis cerebri) of the rat. Scan Electron Microsc. 3: 369-374, 1979b.


Hogan MV, El Sherif Y and Wieraszko A. The modulation of neuronal activity by melatonin: in vitro studies on mouse hippocampal slices. J.Pineal Res. 30: 87-96, 2001.


Huan C, Zhou M, Wu M, Zhang Z and Mei Y. Activation of melatonin receptor increases a delayed rectifier K+ current in rat cerebellar granule cells. Brain Res. 917: 182-190, 2001.


Huerto-Delgadillo L, Anton-Tay F and Benitez-King G. Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J.Pineal Res. 17: 55-62, 1994.


Huie JM, Sharma RP, Coulombe RA Jr.  Diurnal alterations of catecholamines, indoleamines and their metabolites in specific brain regions of the mouse. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 94:575-579, 1989.


Hunt AE, Al Ghoul WM, Gillette MU and Dubocovich ML. Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am.J.Physiol Cell Physiol 280: C110-C118, 2001.


Iigo M, Furukawa K, Hattori A, Ohtani-Kaneko R, Hara M, Suzuki T, Tabata M and Aida K. Ocular melatonin rhythms in the goldfish, Carassius auratus. J.Biol.Rhythms 12: 182-192, 1997a.


Iigo M, Hara M, Ohtani-Kaneko R, Hirata K, Tabata M and Aida K. Photic and circadian regulations of melatonin rhythms in fishes. Biol.Signals 6: 225-232, 1997b.


Imendra KG, Fujiyama R, Miyamoto T, Okada Y and Sato T.  Serotonin inhibits voltage-gated sodium current by cyclic adenosine monophosphate-dependent mechanism in bullfrog taste receptor cells.  Neurosci Lett. 294:151-154, 2000.


Impey S, Mark M, Villacres EC, Poser S, Chavkin C and Storm DR. Induction of CRE-mediated gene expression by stimuli that generate long- lasting LTP in area CA1 of the hippocampus. Neuron 16: 973-982, 1996.


Ireland DR and Abraham WC.  Group I mGluRs increase excitability of hippocampal CA1 pyramidal neurons by a PLC-independent mechanism.  J Neurophysiol. 88:107-116, 2002.                              .

Jackson GL, Jansen H and Kao C. Continuous exposure of Suffolk ewes to an equatorial photoperiod disrupts expression of the annual breeding season. Biol.Reprod. 42: 63-73, 1990.


Jiang ZG, Nelson CS and Allen CN. Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neurons. Brain Res. 687: 125-132, 1995.


Johnston D and Amaral DG. Chapter 11 – Hippocampus; “The Synaptic Organization of the Brain” 4th ed. Edited by Gordon Shepherd, Oxford Press, 1998.


Jontes JD and Smith SJ.  Filopodia, spines, and the generation of synaptic diversity.  Neuron 27:11-14, 2000.


Jun K, Choi G, Yang SG, Choi KY, Kim H, Chan GC, Storm DR, Albert C, Mayr GW, Lee CJ and Shin HS. Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn.Mem. 5: 317-330, 1998.


Kafka MS, Benedito MA, Roth RH, Steele LK, Wolfe WW and Catravas GN. Circadian rhythms in catecholamine metabolites and cyclic nucleotide production. Chronobiol.Int. 101-115, 1986.


Kallal L and Benovic JL. Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking. Trends Pharmacol.Sci. 21: 175-180, 2000.


Kane MA, Johnson A, Nash AE, Boose D, Mathai G, Balmer C, Yohn JJ and Robinson WA. Serum melatonin levels in melanoma patients after repeated oral administration. Melanoma Res. 4: 59-65, 1994.


Kapur, A., Lytton, W. W., Ketchum, K. L., and Haberly, L. B. Regulation of the NMDA component of EPSPs by different components of postsynaptic GABAergic inhibition: computer simulation analysis in piriform cortex. J.Neurophysiol. 78: 2546-2559, 1997.


Kapur, J., Stringer, J. L., and Lothman, E. W. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition. J.Neurophysiol. 4: 417-426, 1989.


Karnup S, Stelzer A.  Temporal overlap of excitatory and inhibitory afferent input in guinea-pig CA1 pyramidal cells.  J Physiol 516:485-504, 1999.


Kennaway DJ, Hugel HM and Rowe SA.  Characterization of the chicken brain melatonin-binding protein using iodinated and tritiated ligands.  J. Pineal Res.  17: 137-148, 1994.


Kennaway DJ, Lushington K, Dawson D, Lack L, van den HC and Rogers N. Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature. J.Pineal Res. 27: 210-220, 1999.


Kirov SA and Harris KM. Dendrites are more spiny on mature hippocampal neurons when synapses are inactivated. Nat.Neurosci. 2: 878-883, 1999.


Kirov SA, Sorra KE and Harris KM. Slices have more synapses than perfusion-fixed hippocampus from both young and mature rats. J.Neurosci. 19: 2876-2886, 1999.


Konecna I, Holecek V, Racek J, Trefil L and Rokyta R. Antioxidant effects of melatonin. Cas.Lek.Cesk. 140: 262-266, 2001.


Krasovich M and Benson B. Effects of reserpine and p-chlorophenylalanine on the circadian rhythm of granulated vesicles in the pinealocytes of mice. Cell Tissue Res. 203: 457-467, 1979.


Kullmann DM, Erdemli G, Asztely F.  LTP of AMPA and NMDA receptor-mediated signals: evidence for presynaptic expression and extrasynaptic glutamate spill-over.  Neuron 17:461-474, 1996.


Kullmann DM, Perkel DJ, Manabe T and Nicoll RA. Ca2+ entry via postsynaptic voltage-sensitive Ca2+ channels can transiently potentiate excitatory synaptic transmission in the hippocampus. Neuron 9: 1175-1183, 1992.


Kumar V, Gwinner E and Van't Hof TJ. Circadian rhythms of melatonin in European starlings exposed to different lighting conditions: relationship with locomotor and feeding rhythms. J.Comp Physiol [A] 186: 205-215, 2000.


Kvetnoy I, Sandvik AK and Waldum HL. The diffuse neuroendocrine system and extrapineal melatonin. J.Mol.Endocrinol. 18: 1-3, 1997.


Laudon M, Nir I and Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 48: 577-583, 1988.


Lee MC, Chung YT, Lee JH, Jung JJ, Kim HS and Kim SU. Antioxidant effect of melatonin in human retinal neuron cultures. Exp.Neurol. 172: 407-415, 2001.


Leon J, Macias M, Escames G, Camacho E, Khaldy H, Martin M, Espinosa A, Gallo MA and Acuna-Castroviejo D. Structure-related inhibition of calmodulin-dependent neuronal nitric- oxide synthase activity by melatonin and synthetic kynurenines. Mol.Pharmacol. 58: 967-975, 2000.


Leon J, Vives F, Crespo E, Camacho E, Espinosa A, Gallo MA, Escames G and Acuna-Castroviejo D. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. J.Neuroendocrinol. 10: 297-302, 1998a.


Leon J, Vives F, Gomez I, Camacho E, Gallo MA, Espinosa A, Escames G and Acuna-Castroviejo D. Modulation of rat striatal glutamatergic response in search for new neuroprotective agents: evaluation of melatonin and some kynurenine derivatives. Brain Res.Bull. 45: 525-530, 1998b.


Li GL, Li P and Yang XL. Melatonin modulates gamma-aminobutyric acid(A) receptor-mediated currents on isolated carp retinal neurons. Neurosci.Lett. 301: 49-53, 2001.


Li P-K, Witt-Enderby PA, Chu GH, Gillen ML and Parekh T.  The Development of a Charged Melatonin Receptor Ligand.  Bioorganic and Medicinal Chemistry Letters 7:2409-2414, 1997.


Lie AA, Becker A, Behle K, Beck H, Malitschek B, Conn PJ, Kuhn R, Nitsch R, Plaschke M, Schramm J, Elger CE, Wiestler OD and Blumcke I. Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability. Ann.Neurol. 47: 26-35, 2000.


Lincoln GA, Almeida OF and Arendt J. Role of melatonin and circadian rhythms in seasonal reproduction in rams. J.Reprod.Fertil.Suppl 30: 23-31, 1981.


Lissin DV, Carroll RC, Nicoll RA, Malenka RC and von Zastrow M. Rapid, activation-induced redistribution of ionotropic glutamate receptors in cultured hippocampal neurons. J.Neurosci. 19: 1263-1272, 1999.


Lissoni P, Barni S, Crispino S, Tancini G and Fraschini F. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur.J.Cancer Clin.Oncol. 25: 789-795, 1989.


Lissoni P, Barni S, Tancini G, Crispino S, Paolorossi F, Lucini V, Mariani M, Cattaneo G, Esposti D and Esposti G.  Clinical study of melatonin in untreatable advanced cancer patients. Tumori 73: 475-480, 1987.


Liu DK, Horner RL and Wojtowicz JM. Time of day determines modulation of synaptic transmission by adenosine in the rat hippocampal slices. Neurosci.Lett. 282: 200-202, 2000.


Luscher C and Frerking M. Restless AMPA receptors: implications for synaptic transmission and plasticity. TINS 24:665-670, 2001.


Luscher C, Nicoll RA, Malenka RC and Muller D. Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat.Neurosci. 3: 545-550, 2000.


Maren S and Baundry M. Properties and mechanisms of synaptic plasticity in the mammalian brain: relationship to learning and memory. Learning and Memory 63:1-18, 1995.


Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI and Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic.Biol.Med. 21: 307-315, 1996.


Mazzucchelli C, Pannacci M, Nonno R, Lucini V, Fraschini F and Stankov BM. The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res.Mol.Brain Res. 39: 117-126, 1996.


McLellan TM, Gannon GA, Zamecnik J, Gil V and Brown GM. Low doses of melatonin and diurnal effects on thermoregulation and tolerance to uncompensable heat stress. J.Appl.Physiol 87: 308-316, 1999.


McMillan TM, Powell GE, Janota I and Polkey CE. Relationships between neuropathology and cognitive functioning in temporal lobectomy patients. J.Neurol.Neurosurg.Psychiatry 50: 167-176, 1987.


Meiri N, Sun MK, Segal Z and Alkon DL. Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense. Proc.Natl.Acad.Sci.U.S.A. 95: 15037-15042, 1998.


Minneman KP, Lynch H and Wurtman RJ. Relationship between environmental light intensity and retina-mediated suppression of rat pineal serotonin-N-acetyl-transferase. Life Sci. 15: 1791-1796, 1974.


Molina-Carballo A, Munoz-Hoyos A, Reiter RJ, Sanchez-Forte M, Moreno-Madrid F, Rufo-Campos M, Molina-Font JA and Acuna-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. J.Pineal Res. 23: 97-105, 1997.


Moller M and Baeres FM.  The anatomy and innervation of the mammalian pineal gland.  Cell Tissue Res. 309:139-150, 2002.


Moretti RM, Marelli MM, Maggi R, Dondi D, Motta M and Limonta P. Antiproliferative action of melatonin on human prostate cancer LNCaP cells. Oncol.Rep. 7: 347-351, 2000.


Morgan PJ, Barrett P, Howell HE and Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem.Int. 24: 101-146, 1994.


Mullins UL and Eison AS. Pharmacologic characterization of melatonin-mediated phosphoinositide hydrolysis in pigeon brain. J.Pineal Res. 17: 33-38, 1994.


Mumby DG, Astur RS, Weisend MP and Sutherland RJ. Retrograde amnesia and selective damage to the hippocampal formation: memory for places and object discriminations. Behav.Brain Res. 97-107, 1999.


Murakami N, Nakamura H, Nishi R, Marumoto N and Nasu T. Comparison of circadian oscillation of melatonin release in pineal cells of house sparrow, pigeon and Japanese quail, using cell perfusion systems. Brain Res. 651: 209-214, 1994.


Musshoff U, Riewenherm D, Berger E, Fauteck JD and Speckmann EJ.  Melatonin receptors in rat hippocampus: molecular and functional investigations.  Hippocampus 12:165-173, 2002.


Neusch C, Bohme V, Riesland N, Althaus M and Moser A.  The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen.  J Neural Transm.107:531-541, 2000.


Niles LP. [3H] melatonin binding in membrane and cytosol fractions from rat and calf brain. J.Pineal Res. 4: 89-98, 1987.


Niles LP and Hashemi F. Picomolar-affinity binding and inhibition of adenylate cyclase activity by melatonin in Syrian hamster hypothalamus. Cell Mol.Neurobiol. 10: 553-558, 1990.


Niles LP and Peace CH. Allosteric modulation of t-[35S]butylbicyclophosphorothionate binding in rat brain by melatonin. Brain Res.Bull. 24: 635-638, 1990.


Niles LP, Wong YW, Mishra RK and Brown GM. Melatonin receptors in brain. Eur.J.Pharmacol. 55: 219-220, 1979.


Niles LP, Ye M, Pickering DS and Ying SW. Pertussis toxin blocks melatonin-induced inhibition of forskolin- stimulated adenylate cyclase activity in the chick brain. Biochem.Biophys.Res.Commun. 178: 786-792, 1991.


Nonno R, Lucini V, Stankov B and Fraschini F. 2-[125I]iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides. Neurosci.Lett. 194: 113-116, 1995.


Nonno R, Pannacci M, Lucini V, Angeloni D, Fraschini F and Stankov BM. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists. Br.J.Pharmacol. 127: 1288-1294, 1999.


Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E and Boutin JA. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J.Biol.Chem. 275: 31311-31317, 2000.


Nowak JZ, Zawilska JB and Trzepizur K.  Alpha 2-adrenergic receptors regulate generation of cyclic AMP in the pineal gland, but not in cerebral cortex of chick.  Pol J Pharmacol.  49:137-141, 1997


Oblap R and Olszanska B. Expression of melatonin receptor transcripts (mel-1a, mel-1b and mel- 1c) in Japanese quail oocytes and eggs. Zygote. 9: 237-244, 2001.

Olney JW, Collins RC and Sloviter RS. Excitotoxic mechanisms of epileptic brain damage. Adv.Neurol. 44: 857-877, 1986.


Oren DA, Turner EH and Wehr TA. Abnormal circadian rhythms of plasma melatonin and body temperature in the delayed sleep phase syndrome. J.Neurol.Neurosurg.Psychiatry 58: 379, 1995.


Ortiz GG, Sanchez-Ruiz Y, Tan DX, Reiter RJ, Benitez-King G and Beas-Zarate C. Melatonin, vitamin E, and estrogen reduce damage induced by kainic acid in the hippocampus: potassium-stimulated GABA release. J.Pineal Res. 31: 62-67, 2001.


Pang SF and Brown GM. Regional concentrations of melatonin in the rat brain in the light and dark period. Life Sci. 33: 1199-1204, 1983.


Pang SF, Tsang CW, Hong GX, Yip PC, Tang PL and Brown GM. Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion, body growth, and aging. J.Pineal Res. 8: 179-192, 1990.


Pang SF, Ayre EA, Poon AM, Pang CS, Yuan H, Wang ZP, Song Y and Brown GM.  Effects of guanosine 5’-O-(3-thiotriphosphate) on 2[125I]-iodomelatonin binding in the chicken lung, brain and kidney: hypothesis of different subtypes of high affinity melatonin receptors.  Biol Signals 2: 27-36, 1993.


Paul P, Lahaye C, Delagrange P, Nicolas JP, Canet E and Boutin JA.  Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs.  J Pharmacol. Exp. Ther. 290:334-340; 1999.


Peoples RW and Weight FF.  Differential alcohol modulation of GABA(A) and NMDA receptors.  Neuroreport 10:97-101, 1999.


Pickard L, Noel J, Duckworth JK, Fitzjohn SM, Henley JM, Collingridge GL and Molnar E.  Transient synaptic activation of NMDA receptors leads to the insertion of native AMPA receptors at hippocampal neuronal plasma membranes.  Neuropharmacology 41:700-713, 2001.


Pierpaoli W, Davies O, Colman C and Regelson W.  Melatonin Miracle: Nature's Sex-Enhancing, Disease-Fighting, Age-Reversing Hormone.  Simon & Schuster, 1993.


Pierrefiche G, Topall G, Courboin G, Henriet I and Laborit H. Antioxidant activity of melatonin in mice. Res.Commun.Chem.Pathol.Pharmacol. 80: 211-223, 1993.


Pickering DS and Niles LP.  2[125I]-iodomelatonin binding sites in hamster and chick exhibit differential sensitivity to prazosin.  J Phar Pharmacol. 41: 356-357, 1989.


Poelchen W, Proctor WR and Dunwiddie TV.  The in vitro ethanol sensitivity of hippocampal synaptic gamma-aminobutyric acid(A) responses differs in lines of mice and rats genetically selected for behavioral sensitivity or insensitivity to ethanol.  J Pharmacol Exp Ther. 295:741-746, 2000.


Raghavan AV, Horowitz JM and Fuller CA. Diurnal modulation of long-term potentiation in the hamster hippocampal slice. Brain Res. 833: 311-314, 1999.


Raynaud F, Mauviard F, Geoffriau M, Claustrat B and Pevet P. Plasma 6-hydroxymelatonin, 6-sulfatoxymelatonin and melatonin kinetics after melatonin administration to rats. Biol.Signals 2: 358-366, 1993.


Recasens M. Putative molecular mechanisms underlying long term potentiation (LTP): the key role of excitatory amino acid receptors. Therapie 50: 19-34, 1995.


Reilly CE. Hippocampus selectively supports episodic memory retrieval. J.Neurol. 248: 1014-1015, 2001.


Reiter RJ. The mammalian pineal gland: structure and function. Am.J.Anat. 162: 287-313, 1981.


Reiter RJ. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J.Neural Transm.Suppl 21: 35-54, 1986.


Reiter RJ. Neuroendocrine effects of light. Int.J.Biometeorol. 35: 169-175, 1991.


Reiter RJ. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review. Braz.J.Med.Biol.Res. 26: 1141-1155, 1993.


Reiter RJ. Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences. Acta Neurobiol.Exp.(Warsz.) 54 Suppl: 31-39, 1994.


Reiter RJ. Functional diversity of the pineal hormone melatonin: its role as an antioxidant. Exp.Clin.Endocrinol.Diabetes 104: 10-16, 1996.


Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog.Neurobiol. 56: 359-384, 1998.


Reiter RJ, Tan D, Kim SJ, Manchester LC, Qi W, Garcia JJ, Cabrera JC, El Sokkary G and Rouvier-Garay V. Augmentation of indices of oxidative damage in life-long melatonin- deficient rats. Mech.Ageing Dev. 110: 157-173, 1999.


Reiter RJ and Tan DX.  Role of CSF in the transport of melatonin.  J Pineal Res. 33:61, 2002.


Reiter RJ and Tan DX.  What constitutes a physiological concentration of melatonin?  J Pineal Res. 34: 79-80, 2003.


Reppert SM. Melatonin receptors: molecular biology of a new family of G protein- coupled receptors. J.Biol.Rhythms 12: 528-531, 1997.


Reppert SM, Perlow MJ, Tamarkin L and Klein DC. A diurnal melatonin rhythm in primate cerebrospinal fluid. Endocrinology 104: 295-301, 1979.


Reppert SM, Weaver DR and Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185, 1994.


Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA and Gusella JF.  Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci 92:8734-8738, 1995.


Rich A, Farrugia G and Rae JL. Effects of melatonin on ionic currents in cultured ocular tissues. Am.J.Physiol 276: C923-C929, 1999.


Roberts E. Some thoughts about GABA and the basal ganglia. Res Publ Assoc Res Nerv Ment Dis. 55: 191-203, 1976.


Rock DM and Taylor CP. Effects of diazepam, pentobarbital, phenytoin and pentylenetetrazol on hippocampal paired-pulse inhibition in vivo. Neurosci.Lett. 65: 265-270, 1986.


Rollag MD, Morgan RJ and Niswender GD. Utilization of the convolution integral to calculate rates of melatonin secretion into blood and CSF of sheep. ISA Trans. 16: 91-96, 1977.


Romero MP, Garcia-Perganeda A, Guerrero JM and Osuna C. Membrane-bound calmodulin in Xenopus laevis oocytes as a novel binding site for melatonin. FASEB J. 12: 1401-1408, 1998.


Ross AW, Webster CA, Thompson M, Barrett P and Morgan PJ. A novel interaction between inhibitory melatonin receptors and protein kinase C-dependent signal transduction in ovine pars tuberalis cells. Endocrinology 139: 1723-1730, 1998.


Rothman SM and Olney JW. Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann.Neurol. 19: 105-111, 1986.


Rousseau A, Petren S, Plannthin J, Eklundh T and Nordin C. Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers. J.Neural Transm. 106: 883-888, 1999.


Saarelainen T, Pussinen R, Koponen E, Alhonen L, Wong G, Sirvio J and Castren E.  Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons have impaired long-term spatial memory but normal hippocampal LTP.  Synapse 38:102-104, 2000.


Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y and Sugiyama H. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 1995.Jan.12.373. 151-155, 1995.


Sandyk R.  Pineal melatonin functions and the depression of Parkinson's disease: a hypothesis. Int.J.Neurosci. 51: 73-77, 1990.


Sandyk R and Kay SR. Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia): a hypothesis. Funct.Neurol. 5: 165-170, 1990.


Savaskan E, Olivieri G, Brydon L, Jockers R, Krauchi K, Wirz-Justice A and Muller-Spahn F. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. Neurosci.Lett. 308: 9-12, 2001.


Sayin U, Rutecki PA, Mellanby J and Sutula TP.  Gamma-vinyl GABA reduces paired pulse inhibition in the rat dentate gyrus in vivo and in vitro. Epilepy Research 44:109-117, 2001.


Schulz PE, Cook EP and Johnston D.  Using paired-pulse facilitation to probe the mechanism for long-term potentiation (LTP).  J Physiol (Paris) 89:3-9, 1995.


Schuster C, Gauer F, Malan A, Recio J, Pevet P and Masson-Pevet M. The circadian clock, light/dark cycle and melatonin are differentially involved in the expression of daily and photoperiodic variations in mt(1) melatonin receptors in the Siberian and Syrian hamsters. Neuroendocrinology 74: 55-68, 2001.


Scoville WB and Milner B. Loss of recent memory after bilateral hyppocampal lesions. Journal of Neurol. Neurosurg and Psychiat 20: 11-21, 1957.


Segal M. The action of serotonin in the rat hippocampal slice preparation. J.Physiol 303: 423-439, 1980.


Semyanov A and Kullmann DM.  Kainate receptor-dependent axonal depolarization and action potential initiation in interneurons.  Nat Neurosci.  4:718-723, 2001.


Semm P, Demaine C and Vollrath L. Electrical responses of pineal cells to melatonin and putative transmitters. Evidence for circadian changes in sensitivity. Exp.Brain Res. 43: 361-370, 1981.


Sharma M, Palacios-Bois J, Schwartz G, Iskandar H, Thakur M, Quirion R and Nair NP. Circadian rhythms of melatonin and cortisol in aging. Biol.Psychiatry 25: 305-319, 1989.


Shida CS, Castrucci AM and Lamy-Freund MT. High melatonin solubility in aqueous medium. J.Pineal Res. 16: 198-201, 1994.


Simson PE, Criswell HE and Breese GR.  Inhibition of NMDA-evoked electrophysiological activity by ethanol in selected brain regions: evidence for ethanol-sensitive and ethanol-insensitive NMDA-evoked responses.  Brain Res. 607: 9-16, 1993.


Sinclair JG and Lo GF.  Ethanol blocks tetanic and calcium-induced long-term potentiation in the hippocampal slice.  Gen Pharmacol. 17:231-233, 1986.


Siuciak JA, Krause DN and Dubocovich ML. Quantitative pharmacological analysis of 2-125I-iodomelatonin binding sites in discrete areas of the chicken brain. J.Neurosci. 11: 2855-2864, 1991.


Skaper SD, Ancona B, Facci L, Franceschini D and Giusti P. Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB J. 12: 725-731, 1998.


Skinner DC and Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 140: 4399-4405, 1999.


Slanar O, Pelisek V, Vanecek J. Melatonin inhibits pituitary adenylyl cyclase activating polypetide-     induced increase of cyclic AMP accumulation and [Ca2+ ]i in cultured cells of neonatal  rat pituitary. Neurochem Int 36: 213-219, 2000.



Somova EV, Kolodub FA and Bondarenko LA. Chronobiological aspects of melatonin-produced antioxidant effects in senescent rats. Bull.Exp.Biol.Med. 132: 887-889, 2001.


Southgate GS, Daya S and Potgieter B. Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. J.Chem.Neuroanat. 14: 151-156, 1998.


Stankov B, Capsoni S, Lucini V, Fauteck J, Gatti S, Gridelli B, Biella G, Cozzi B and Fraschini F. Autoradiographic localization of putative melatonin receptors in the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus. Neuroscience 52: 459-468, 1993.


Stankov B, Cozzi B, Lucini V, Capsoni S, Fauteck J, Fumagalli P and Fraschini F. Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding. Neurosci.Lett. 133: 68-72, 1991.


Stehle J, Vanecek J and Vollrath L. Effects of melatonin on spontaneous electrical activity of neurons in rat suprachiasmatic nuclei: an in vitro iontophoretic study. J.Neural Transm. 78: 173-177, 1989.


Sugden D, Pickering H, The MT and Garratt PJ.  Melatonin receptor pharmacology: toward subtype specificity.  Biol Cell 89:531-537, 1997.


Sun W, Salvi RJ.  Dopamine modulates sodium currents in cochlear spiral ganglion neurons. Neuroreport. 12:803-807, 2001.


Suzuki T. Messengers from the synapses to the nucleus (MSNs) that establish late phase of long-term potentiation (LTP) and long-term memory. Neurosci.Res. 25: 1-6, 1996.


Tan DX, Manchester LC, Burkhardt S, Sainz RM, Mayo JC, Kohen R, Shohami E, Huo YS, Hardeland R and Reiter RJ. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15: 2294-2296, 2001.


Tan DX, Poeggeler B, Reiter RJ, Chen LD, Chen S, Manchester LC and Barlow-Walden LR. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70: 65-71, 1993.


Thrun LA, Moenter SM, O'Callaghan D, Woodfill CJ and Karsch FJ. Circannual alterations in the circadian rhythm of melatonin secretion. J.Biol.Rhythms 10: 42-54, 1995.


Tomatis ME, Orias R.  Changes in melatonin concentration in pineal gland in rats exposed to continuous light or darkness.  Acta Physiol Lat Am 17:227-233, 1967.


Tosini G, Bertolucci C and Foa A. The circadian system of reptiles: a multioscillatory and multiphotoreceptive system. Physiol Behav. 72: 461-471, 2001.


Touitou Y, Fevre M, Lagoguey M, Carayon A, Bogdan A, Reinberg A, Beck H, Cesselin F and Touitou C. Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J.Endocrinol. 91: 467-475, 1981.


Tricoire H, Locatelli A, Chemineau P and Malpaux B. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 143: 84-90, 2002.


Tsao P and von Zastrow M. Downregulation of G protein-coupled receptors. Curr.Opin.Neurobiol. 10: 365-369, 2000.


Tsien JZ, Huerta PT, Tonegawa S.  The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory.  Cell 87:1327-1338, 1996.


Turek FW, Zee P, Van Reeth O. Melatonin and aging.  Adv. Exp. Med. Biol. 460:435-440, 1999.


Ubeda A, Trillo MA, House DE and Blackman CF. Melatonin enhances junctional transfer in normal C3H/10T1/2 cells. Cancer Lett. 91: 241-245, 1995.


Upson H and Benson H.  Effects of blinding on the ultrastructure of mouse pinealocytes with particular emphasis on the dense core vesicles. Cell Tissue Res. 183:491-498, 1977.


Vacas MI, Keller-Sarmiento MI and Cardinali DP. Pineal methoxyindoles depress calcium uptake by rat brain synaptosomes. Brain Res. 294: 166-168, 1984.


Vakkuri O, Leppaluoto J and Vuolteenaho O. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol.(Copenh) 106: 152-157, 1984.


Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev. 78: 687-721, 1998.


Vanecek J and Watanabe K. Melatonin inhibits the increase of cyclic AMP in rat suprachiasmatic neurons induced by vasoactive intestinal peptide. Neurosci.Lett. 252: 21-24, 1998.


Varga Z, Panyi G, Peter M Jr., Pieri C, Csecsei G, Damjanovich S and Gaspar R Jr. Multiple binding sites for melatonin on Kv1.3. Biophys.J. 80: 1280-1297, 2001.


Velazquez JL and Carlen PL. Synchronization of GABAergic interneuronal networks during seizure-like activity in the rat horizontal hippocampal slice. Eur.J.Neurosci. 11: 4110-4118, 1999.


Veylon R. [The third eye. Confirmation of the role of the epiphysis as a regulator of sexual activity in birds]. Nouv.Presse Med. 9: 2045, 1980.


Vivien-Roels B, Arendt J and Bradtke J. Circadian and circannual fluctuations of pineal indoleamines (serotonin and melatonin) in Testudo hermanni Gmelin (Reptilia, Chelonia). I. Under natural conditions of photoperiod and temperature. Gen.Comp Endocrinol. 37: 197-210, 1979.


Waldhauser F and Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann.N.Y.Acad.Sci. 453: 205-214, 1985.


Waldhauser F, Ehrhart B and Forster E. Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions. Experientia 49: 671-681, 1993.


Wall PM and Messier C. Concurrent modulation of anxiety and memory. Behav. Brain Res. 109:229-241, 2000a.


Wall PM and Messier C.  U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alteration memory in mice. Brain Res. 856:259-280, 2000b.


Wan FJ, Berton F, Madamba SG, Francesconi W, Siggins GR.  Low ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in hippocampal pyramidal neurons only after block of GABAB receptors.  Proc Natl Acad Sci USA 93:5049-5054, 1996.


Wan Q, Man HY, Liu F, Braunton J, Niznik HB, Pang SF, Brown GM and Wang YT. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors. Nat.Neurosci. 2: 401-403, 1999.


Wang JH and Kelly P. Calcium-calmodulin signalling pathway up-regulates glutamatergic synaptic function in non-pyramidal, fast spiking rat hippocampal CA1 neurons. J.Physiol 533: 407-422, 2001.


Wang JH and Kelly PT. Postsynaptic injection of CA2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron 15: 443-452, 1995.


Wang JH and Kelly PT. Regulation of synaptic facilitation by postsynaptic Ca2+/CaM pathways in hippocampal CA1 neurons. J.Neurophysiol. 76: 276-286, 1996a.


Wang JH and Kelly PT. The balance between postsynaptic Ca(2+)-dependent protein kinase and phosphatase activities controlling synaptic strength. Learn.Mem. 170-181, 1996b.


Wang JH and Kelly PT. Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. J.Neurophysiol. 78: 2707-2716, 1997.


Weaver DR, Stehle JH, Stopa EG and Reppert SM. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J.Clin.Endocrinol.Metab 76: 295-301, 1993.


Webley GE, Mehl H and Willey KP. Validation of a sensitive direct assay for melatonin for investigation of circadian rhythms in different species. J.Endocrinol. 106: 387-394, 1985.


White JA, Baxter DA, Byrne JH.  Analysis of the modulation by serotonin of a voltage-dependent potassium current in sensory neurons of Aplysia.  Biophys J. 66:710-718, 1994.


Wiechmann AF and Smith AR. Melatonin receptor RNA is expressed in photoreceptors and displays a diurnal rhythm in Xenopus retina. Brain Res.Mol.Brain Res. 91: 104-111, 2001.


Wieraszko A. Uptake of D-[3H]aspartic acid by hippocampal slices: the influence of low and high frequency activation of nerve endings. Brain Res. 259: 324-326, 1983.


Wiesenberg I, Missbach M, Kahlen JP, Schrader M and Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23: 327-333, 1995.


Winczyk K, Pawlikowski M and Karasek M. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer. J.Pineal Res. 31: 179-182, 2001.


Wirz-Justice A, Kafka MS, Naber D and Wehr TA. Circadian rhythms in rat brain alpha- and beta-adrenergic receptors are modified by chronic imipramine. Life Sci. 27: 341-347, 1980.


Witt-Enderby PA, Chu GH, Gillen ML and Li PK. Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors. J.Med.Chem. 40: 4195-4198, 1997.


Witt-Enderby PA and Li PK. Melatonin receptors and ligands. Vitam.Horm. 58: 321-354, 2000.


Won JS, Song DK, Huh SO, Kim YH and Suh HW. Effect of melatonin on the regulation of proenkephalin and prodynorphin mRNA levels induced by kainic acid in the rat hippocampus. Hippocampus 10: 236-243, 2000.


Wu FS, Yang YC and Tsai JJ. Melatonin potentiates the GABA(A) receptor-mediated current in cultured chick spinal cord neurons. Neurosci.Lett. 260: 177-180, 1999.


Xiao MY, Zhou Q and Nicoll RA. Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors. Neuropharmacology 41: 664-671, 2001.


Xu MF, Tang PL, Qian ZM and Ashraf M. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci. 68: 889-901, 2001.


Yu HS, Pang SF, Tang PL and Brown GM. Persistence of circadian rhythms of melatonin and N-acetylserotonin in the serum of rats after pinealectomy. Neuroendocrinology 32: 262-265, 1981.


Yuan H and Pang SF. [125I]melatonin binding sites in membrane preparations of quail brain: characteristics and diurnal variations. Acta Endocrinol.(Copenh) 122: 633-639, 1990.


Zatz M, Gastel JA, Heath JR III and Klein DC. Chick pineal melatonin synthesis: light and cyclic AMP control abundance of serotonin N-acetyltransferase protein. J.Neurochem. 74: 2315-2321, 2000.


Zawilska JB and Nowak JZ. Melatonin: from biochemistry to therapeutic applications. Pol.J.Pharmacol. 51: 3-23, 1999.


Zawilska JB, Vivien-Roels B, Skene DJ, Pevet P, and Nowak JZ. Phase-shifting effects of light on the circadian rhythms of 5- methoxytryptophol and melatonin in the chick pineal gland. J.Pineal Res. 29:1-7, 2000.


Zeise ML and Semm P. Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. J.Comp Physiol [A] 157: 23-29, 1985.


Zhang Q and Zhang J.  Effect of melatonin on the spatial and temporal changes of [Ca2+ ]i in single living cells of cortical neurons by laser scanning confocal microscopy. Chin Med J 113:558-562, 2000.


Zhou JJ, Esteban JA, Hayashi Y, Malinow R.  Postnatal synaptic potentiation: delivery of Glu4-containing AMPA receptors by spontaneous activity. Nature Neurosci 3: 1098-1106, 2000.


Zhu JJ, Esteban JA, Hayashi Y, and Malinow R. Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat.Neurosci. 3: 1098-1106, 2000.


Zisapel N and Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain Res. 272: 378-381, 1983.


Zucker RS.  Short-term synaptic plasticity. Ann Rev Neurosci 12: 13-31, 1989.